Workshop proceeding - final.pdf - Faculty of Information and ...
Workshop proceeding - final.pdf - Faculty of Information and ...
Workshop proceeding - final.pdf - Faculty of Information and ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The role <strong>of</strong> mitochondria in atrial fibrillation with Rheumatic heart<br />
valvular disease<br />
Runwei Ma 1,2 *<br />
* Invited speaker<br />
1. Department <strong>of</strong> Cardiovascular Surgery, The First Hospital Affiliated Kunming Medical<br />
College, Yunnan 650032, P.R.China<br />
2. Department <strong>of</strong> Cardiothoracic Surgery, Monash Hospital, Clayton, Vic 3168, Australia<br />
Rheumatic heart disease (RHD) is a common disease in developing country. Most <strong>of</strong> the<br />
disease is concomitant with Atrial Fibrillation (AF). The mechanism <strong>of</strong> AF in RHD is<br />
different with other AF. We know that the function <strong>of</strong> mitochondria is associated with<br />
cardiomyocyte necrosis <strong>and</strong> apoptosis which will remodel the structure <strong>of</strong> atrium, especial<br />
fibrosis. Tissue fibrosis results from an accumulation <strong>of</strong> fibrillar collagen deposits, occurring<br />
most commonly as a reparative process to replace degenerating myocardial parenchyma with<br />
concomitant reactive fibrosis, which causes interstitial expansion. Fibrosis is a hallmark <strong>of</strong><br />
arrhythmogenic structural remodeling. In addition, there is great difference in heart function<br />
<strong>of</strong> patients with same detriment <strong>of</strong> valves, as well as AF. We postulate that there is a<br />
difference in mitochondria’s function which is influenced by gene mutation or difference <strong>of</strong><br />
mitochondria which caused by inheritance or disease. We plan to use DNA chip technique to<br />
study the difference <strong>of</strong> mitochondrial gene in RHD patients with <strong>and</strong> without AF.<br />
BIO: Runwei Ma is the head <strong>of</strong> the Department <strong>of</strong> Cardiovascular Surgery in the First<br />
Affiliated Hospital <strong>of</strong> Kunming Medical College, <strong>and</strong> is responsible for the Cardiovascular<br />
Surgeon. He has successfully applied a number <strong>of</strong> novel techniques in surgical operations. Dr<br />
Runwei got his MD degree in Kunming Medical College in 2007 <strong>and</strong> now he is a visiting<br />
scholar in the Medical Center Monash University. His research focuses on the improvement<br />
<strong>of</strong> cardiovascular conditions using both traditional drug treatment <strong>and</strong> genetic therapy.<br />
7